We are live on ! Find out more
PCM

Piermont Capital Management Portfolio holdings

AUM $211M
1-Year Est. Return 8.09%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
-8.09%
3 Year Est. Return
+33.18%
5 Year Est. Return
+53.13%
10 Year Est. Return
–
AUM
$420M
AUM Growth
-$18.1M
Cap. Flow
-$22M
Cap. Flow %
-5.25%
Top 10 Hldgs %
10.15%
Holding
292
New
47
Increased
34
Reduced
89
Closed
50

Top Buys

Rank Stock Value
1
RMBS icon
Rambus
RMBS
+$3.25M
2
AVA icon
Avista
AVA
+$3.19M
3
IBKC
IBERIABANK Corp
IBKC
+$3.14M
4
AMKR icon
Amkor Technology
AMKR
+$3.13M
5
WTFC icon
Wintrust Financial
WTFC
+$3.12M

Top Sells

Rank Stock Value
1
PIPR icon
Piper Sandler
PIPR
+$4.11M
2
PB icon
Prosperity Bancshares
PB
+$3.68M
3
ONB icon
Old National Bancorp
ONB
+$3.62M
4
DIN icon
Dine Brands
DIN
+$3.46M
5
INN
Summit Hotel Properties
INN
+$3.39M

Sector Composition

Rank Sector Weight
1 Financials 20.58%
2 Industrials 17.44%
3 Technology 13.98%
4 Consumer Discretionary 10.56%
5 Healthcare 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VNDA icon
226
Vanda Pharmaceuticals
VNDA
$305M
$529K 0.13%
37,800
– –
CSOD
227
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$529K 0.13%
13,610
– –
DPZ icon
228
Domino's
DPZ
$11.6B
$525K 0.13%
2,850
– –
ASRT
229
DELISTED
Assertio
ASRT
$502K 0.12%
667
– –
LXRX icon
230
Lexicon Pharmaceuticals
LXRX
$1.04B
$500K 0.12%
34,870
– –
CCXI
231
DELISTED
ChemoCentryx, Inc.
CCXI
$484K 0.12%
66,498
– –
NTUS
232
DELISTED
Natus Medical Inc
NTUS
$484K 0.12%
12,320
– –
CIVI
233
DELISTED
Civitas Solutions, Inc.
CIVI
$483K 0.12%
+26,336
New +$488K
OMED
234
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$481K 0.11%
+52,195
New +$458K
AMPH icon
235
Amphastar Pharmaceuticals
AMPH
$937M
$474K 0.11%
32,683
+6,530
+25% +$103K
FLR icon
236
Fluor
FLR
$8B
$441K 0.11%
8,380
– –
AEE icon
237
Ameren
AEE
$30.3B
$396K 0.09%
7,250
– –
IWN icon
238
iShares Russell 2000 Value ETF
IWN
$14.6B
$390K 0.09%
+3,300
New +$392K
KDNY
239
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$386K 0.09%
+7,180
New +$406K
ANDV
240
DELISTED
Andeavor
ANDV
$375K 0.09%
4,630
-410
-8% -$34.3K
AMAG
241
DELISTED
AMAG Pharmaceuticals
AMAG
$337K 0.08%
14,950
– –
TRVN
242
DELISTED
Trevena, Inc.
TRVN
$335K 0.08%
146
+23
+19% +$78.3K
AMN icon
243
AMN Healthcare
AMN
$1.38B
– –
-34,580
Closed -$1.33M
ANF icon
244
Abercrombie & Fitch
ANF
$4.98B
– –
-70,830
Closed -$850K
AVY icon
245
Avery Dennison
AVY
$13.4B
– –
-9,290
Closed -$652K
AXTA icon
246
Axalta
AXTA
$8.13B
– –
-16,260
Closed -$442K
BWA icon
247
BorgWarner
BWA
$14B
– –
-21,743
Closed -$755K
CDE icon
248
Coeur Mining
CDE
$17.6B
– –
-196,365
Closed -$1.78M
CDP icon
249
COPT Defense Properties
CDP
$4.23B
– –
-94,907
Closed -$2.96M
CHRS icon
250
Coherus Oncology
CHRS
$210M
– –
-19,060
Closed -$537K
8 9
10
11 12

Similar funds

WAM
Watermark Asset Management San Ramon, California $216M AUM 7.54% 1-Year Est. Return
GIM
Greystone Investment Management Cincinnati, Ohio $195M AUM 6.99% 1-Year Est. Return
PPC
Precision Path Capital New York $233M AUM
MA
Marshwinds Advisory St Simons Island, Georgia $187M AUM 1.79% 1-Year Est. Return
PC
Palo Capital Newport Beach, California $236M AUM 5.33% 1-Year Est. Return
HCG
HNA Capital Group Haikou, China $243M AUM 36.37% 1-Year Est. Return
WA
WealthTrust-Arizona Scottsdale, Arizona $172M AUM 6.58% 1-Year Est. Return
VAM
Visionary Asset Management Houston, Texas $252M AUM 3.81% 1-Year Est. Return

Piermont Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Piermont Capital Management held 292 positions worth $420M, down 4.1% from $438M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Piermont Capital Management withdrew a net $22M in Q1 2017, closing 50 positions and reducing 89 holdings. Its most notable exit was Piper Sandler, an estimated $4.11M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Industrials and Technology.

Against the trend, Piermont Capital Management opened a new position in Avista worth $3.18M.

  • Piermont Capital Management's largest Q1 2017 buy was Avista: 81,350 shares worth $3.18M.
  • Piermont Capital Management added most to Rambus in Q1 2017, an estimated $3.25M increase.
  • Piermont Capital Management's biggest Q1 2017 reduction was Pennsylvania Real Estate Investment Trust, cutting an estimated $1.85M.
  • Piermont Capital Management fully exited Piper Sandler in Q1 2017, selling an estimated $4.11M.
  • Piermont Capital Management's ten largest holdings make up 10% of its $420M portfolio in Q1 2017.
  • Piermont Capital Management opened 47 new positions and closed 50 in Q1 2017.
  • Piermont Capital Management's portfolio value fell 4.1% quarter-over-quarter to $420M.

Based on Piermont Capital Management's 13F filing for Q1 2017, filed 11 May 2017.